Skip to Content
Merck

Medical therapy for acquired urinary incontinence in dogs.

International journal of pharmaceutical compounding (2012-10-18)
Katie Hill, Dinah Jordan, Jody Ray, Andrew A Mays, Katie Griffin
ABSTRACT

The objective of this case report was to review acquired canine urethral incontinence in a case of a 2-year-old beagle that presented for inappropriate urination. Commercially available medications, as well as compounded medical therapeutic options, were reviewed. Diagnostic results revealed cystitis, which responded to the prescribed antibiotics. The incontinence issue remained. Compounded diethylstilbestrol was prescribed and dispensed to achieve successful clinical results. The role of the compounding pharmacist was vital to achieve appropriate dosing of a drug no longer commercially available.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Estriol, meets USP testing specifications
Sigma-Aldrich
Estriol, ≥97%
Supelco
Estriol solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
Diethylstilbestrol, VETRANAL®, analytical standard
Sigma-Aldrich
Diethylstilbestrol, ≥99% (HPLC)